We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

Fate of New York’s PTSD Bill Rests With Cuomo

Gage PeakePublished on June 20, 2017 · Last updated July 28, 2020

A bipartisan proposal that would add post-traumatic stress disorder (PTSD) as a qualifying condition for New York’s medical marijuana program has received final approval from state lawmakers. It now heads to the desk of Gov. Andrew Cuomo for final approval.

The Senate approved S 5629 on a 50–13 vote on Tuesday. The Assembly version of the bill, A 7006, passed with overwhelming support (131­–8) in May.

Veterans advocates, who pushed hard for the  addition, said the move would be a boon to the health and well being of those who served their country and would otherwise have to move out of the state to obtain cannabis legally.

“Military veterans, first responders, and victims who have survived assault all deserve society’s respect and the best available treatments; they should not have to abandon their homes and move to another state in order to seek access to medical marijuana,” Michael Krawitz, executive director of Veterans for Medical Cannabis Access, said in a statement. “This is compassionate and commonsense legislation that is widely supported by the public as well as lawmakers from both sides of the aisle.”

Kate Bell, legislative counsel for the Marijuana Policy Project, added the group hopes Cuomo wastes no time in signing the bill.

“State lawmakers are standing up for thousands of New Yorkers who are suffering from PTSD and might benefit from medical marijuana,” she said. “We hope Gov. Cuomo will do the same and sign this important legislation. With a single swipe of his pen, he can help countless people find relief.”

The bipartisan bill was introduced by Sen. Diane Savino (D-Staten Island) and seven co-sponsors, including Sen. Martin Golden (R-Brooklyn), who previously opposed medical marijuana legislation. The Assembly version was introduced by Assembly Health Committee Chair Richard N. Gottfried (D-Manhattan) with a bipartisan coalition of more than three dozen co-sponsors.

Out of the 29 states with medicinal marijuana programs, 26 of them allow patients with PTSD to qualify for medical marijuana. Both Colorado and Vermont recently added PTSD to their respective lists, and patients in New Hampshire are waiting for the governor’s signature on a bill recently passed by the Legislature.

“In the past year, 11 more states have approved allowing trauma survivors to use cannabis for PTSD. Now only three medical cannabis states exclude PTSD patients,” Bell of MPP said. “Senate Majority Leader John Flanagan and his colleagues should be commended for addressing the needs of New York residents who are dealing with this terrible condition, including our veterans. By signing this legislation, Gov. Cuomo can ensure New Yorkers don’t get left behind.”

Related Stories

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
Cuomomedical marijuanaNew Yorkptsdtreatment
Gage Peake
Gage Peake
Gage Peake is a former staff writer for Leafly, where he specialized in data journalism, sports, and breaking news coverage. He's a graduate of the University of Nebraska-Lincoln's College of Journalism and Mass Communications.
View Gage Peake's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.